@Article{biocell.2023.028567,
AUTHOR = {CARL RANDALL HARREL, VALENTIN DJONOV, ANA VOLAREVIC, DRAGICA PAVLOVIC, VLADISLAV VOLAREVIC},
TITLE = {The role of mesenchymal stem cell-derived exosomes in tumor progression},
JOURNAL = {BIOCELL},
VOLUME = {47},
YEAR = {2023},
NUMBER = {8},
PAGES = {1757--1769},
URL = {http://www.techscience.com/biocell/v47n8/53800},
ISSN = {1667-5746},
ABSTRACT = {Exosomes derived from mesenchymal stem cells (MSC-Exos) are nano-sized extracellular vesicles enriched with bioactive molecules, such as microRNAs, enzymes, cytokines, chemokines, immunomodulatory, trophic, and growth factors. These molecules regulate the survival, phenotype, and function of malignant and tumor-infiltrated immune cells. Due to their nano-size and bilayer lipid envelope, MSC-Exos can easily bypass biological barriers and may serve as drug carriers to deliver chemotherapeutics directly into the tumor cells. Here, we summarize current knowledge regarding molecular mechanisms responsible for MSC-Exos-dependent modulation of tumor progression and discuss insights regarding the therapeutic potential of MSC-Exos in the treatment of malignant diseases.},
DOI = {10.32604/biocell.2023.028567}
}